China: A ‘Known Unknown’ Risk in Equity Portfolios Emerging Markets, Equities, Webinars The recent cascade of new regulations, impacting a wide range of sectors from fintech to property and private tuition, was widely perceived as a retrograde move by the government. With the economy largely market-driven over the last four decades, these sudden moves have taken equity markets by surprise. Read More
Cbus Mulls Higher Asia Tilt Emerging Markets, Equities, Women in Finance After more formally splitting out emerging markets from its global equities portfolio, Cbus is now considering whether it would benefit from a larger tilt towards Asia, which could incorporate a dedicated China exposure. Read More
Climate Risk and the Data Revolution Emerging Markets, ESG, Factors, Quant & Systematic A revolution in data mapping the effects of climate change has created opportunities for investors to develop a more granular picture of the risks involved, while it is also likely to lead to a gradual repricing of assets, PGIM says. Read More
FDI Eyes Chinese Bond Market Emerging Markets, Fixed Income & Credit Institutional investors are gearing up to buy into the Chinese government bond market, as more global indices are adding these bonds, SSGA says. Read More
Healthcare Innovation in China Emerging Markets, Equities, Innovation, Webinars Many investors would be surprised to learn that China is transforming its healthcare ecosystem into one that is incubating a promising culture for future healthcare innovation. Read More
The Future of Chinese Private Equity Emerging Markets, Private & Alternative Markets The Chinese private equity (PE) market is at an inflection point after more than a decade of rapid growth. Dan Purves speaks to Cambridge Associates’ Vish Ramaswami about what the next 10 years might look like. From an asset owner’s perspective, 10 years ago, there were relatively few managers available and most employed a generalist […] Read More
Investing in Chinese Health Tech Emerging Markets, Equities, Women in Finance China’s healthcare and biotechnology industries have seen rapid growth in recent years. We speak with Jennison’s Sara Moreno about the opportunities and the impact of the pandemic. Read More
Aware Super Still Sees Opportunities in China Asset Owners, Emerging Markets, Equities, Women in Finance Aware Super still sees plenty of opportunities in the domestic share market in China but acknowledges that current developments have given the fund pause to think about its approach to expanding its allocation, according to Jo Cornwell, Portfolio Manager, Growth Assets at the fund. Read More
China and the Search for Semiconductors Emerging Markets, Equities As semiconductors replace oil as the key commodity in the modern global economy, Wasatch’ Ajay Krishnan says Read More
![[i3] Equities Webinar with PineBridge Investments | China: A ‘Known Unknown’ Risk in Equity Portfolios](https://i3-invest.com/wp-content/uploads/2021/12/i3-Equities-Webinar-with-PineBridge-Investments-web-680x340.jpg)
![[i3] Equities Webinar co-hosted with Jennison Associates: Healthcare Innovation in China](https://i3-invest.com/wp-content/uploads/2021/07/i3-Equities-Webinar-co-hosted-with-Jennison-Associates-680x383.jpg)
